FDMT Competitors & Alternatives
Compare 4D Molecular Therapeutics Inc with similar stocks in the same industry
Biotechnology
FDMT
Main Stock$11.30
Tradestie Score
56
Market Cap
$407.71M
Revenue Growth
216.6%
Analyst Upside
+149.8%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$146.03
|
$699.30M | - | 61 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.34
|
$688.47M | - | 56 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.10
|
$670.30M | - | 48 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.34
|
$665.30M | - | 59 | Compare |
|
ANL
ANL
|
$9.24
|
$635.61M | - | 49 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.90
|
$626.91M | - | 59 | Compare |
|
SVRA
Savara Inc.
|
$5.74
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
More FDMT Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry